Pancreatic Cancer Action Network Press Release NCI Progress Report

Home About the Pancreatic Cancer Action Network News / Press Center 2011 Press Releases Pancreatic Cancer Action Network Press Release NCI Progress Report

January 20, 2011

FOR IMMEDIATE RELEASE

ONLINE PHYSICIAN EDUCATION PROGRAM OUTLINES TREATMENT STRATEGIES FOR PANCREATIC CANCER

ALEXANDRIA, VA and MANHATTAN BEACH, CA – The American Society of Clinical Oncology (ASCO) and the Pancreatic Cancer Action Network today announced a partnered effort to educate physicians about treatment strategies for pancreatic cancer. From a joint collaboration between ASCO University®, the Pancreatic Cancer Action Network, and The ASCO Cancer Foundation®, the 2011 ASCO Tumor Board: Pancreatic Cancer highlights the current treatment strategies and novel therapeutics that exist for this disease, the fourth leading cause of cancer death in the United States.

Seventy five percent of patients with pancreatic cancer die within the first year of diagnosis and only six percent survive more than five years. As part of this ASCO University tumor board series on pancreatic cancer treatments, the program will focus on radiotherapy options and new chemotherapy regimens.

The tumor board pairs pancreatic cancer experts and technology through ASCO University, ASCO’s online physician education forum, to create an open environment for oncology professionals to learn about treatment approaches for this disease. Doctors who log on to the 2011 ASCO Tumor Board: Pancreatic Cancer, will be able to walk through a patient case presented by leading experts in pancreatic cancer care who represent both ASCO and the Pancreatic Cancer Action Network and also contribute to the discussion. The case presentation and discussion is led by Eileen O’Reilly, MD, Medical Oncologist from Memorial Sloan-Kettering Cancer Center and Christopher Crane, MD, Radiation Oncologist from The University of Texas M. D. Anderson Cancer Center. Both serve as members of the Pancreatic Cancer Action Network Medical Advisory Council.

“Pancreatic cancer remains a challenge and we need to work together as a physician community in order to improve outcomes for our patients,” said Ronald Blum, MD, Chair of ASCO’s Education Production Subcommittee. “This Tumor Board on ASCO University allows us to interact and learn about the newest technologies and therapies for treating our patients with pancreatic cancer.”

“The Pancreatic Cancer Action Network is proud to participate in the continuing education of healthcare professionals who treat pancreatic cancer patients,” stated Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network. “We are thrilled to collaborate with ASCO on this important project and expand our outreach efforts to oncologists and healthcare professionals to ensure the most cutting edge treatment is available.”

The case presentation for Pancreatic Cancer Tumor Board will be available for one year, while the online discussion forum will be open through Feb 18th. Once closed, the key discussion points noted in the forum will be summarized and made available in the module containing the presentation. Physicians can log on to the 2011 ASCO Tumor Board: Pancreatic Cancer for free by visiting http://university.asco.org/tumorboards.

About the American Society of Clinical Oncology (ASCO)
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With nearly 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.Cancer.Net.

About The ASCO Cancer Foundation
The ASCO Cancer Foundation funds research and education programs both in the U.S. and abroad. By harnessing the knowledge of nearly 30,000 oncology professionals in the American Society of Clinical Oncology (ASCO), we help deliver physician-approved information directly to those in need. Through these efforts, we improve the lives of those affected by cancer. For more information, visit www.ascocancerfoundation.org.

About the Pancreatic Cancer Action Network:
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research—and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.

The Pancreatic Cancer Action Network fills the void of information and options by giving patients and caregivers reliable, personalized information they need to make informed decisions. It creates a sense of hope and community so no one has to face pancreatic cancer alone. The organization helps support individuals and communities all across the country to work together to raise awareness and funds to find a cure for pancreatic cancer.

###

MEDIA INQUIRIES ONLY CONTACT:
Jennifer Rosen
Senior Manager, Public Relations
Pancreatic Cancer Action Network
Direct: 310-706-3362
Email:jrosen@pancan.org

ALL OTHER INQUIRIES, PLEASE CALL THE PANCREATIC CANCER ACTION NETWORK AT 877-272-6226 OR EMAIL INFO@PANCAN.ORG.

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.